INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
Scope & Guideline
Unveiling the complexities of genetics and clinical applications.
Introduction
Aims and Scopes
- Molecular Mechanisms of Disease:
The journal frequently publishes studies elucidating the molecular underpinnings of various diseases, including cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. This includes research on gene expression, signaling pathways, and cellular responses. - Therapeutic Strategies and Drug Development:
A significant focus is placed on novel therapeutic strategies and drug development, particularly in cancer therapy and regenerative medicine. This encompasses studies on small molecules, biologics, and advanced therapies such as gene editing and stem cell applications. - Role of Non-Coding RNAs and Epigenetics:
The journal showcases research on the regulatory roles of non-coding RNAs, including microRNAs and long non-coding RNAs, in gene expression and their implications in disease processes and therapy. - Immunology and Inflammation:
Studies related to the immune system, inflammatory responses, and their implications in diseases such as autoimmune disorders and cancer are prominent, highlighting the intersection of molecular medicine and immunology. - Translational Research:
The journal emphasizes translational research that connects laboratory findings with clinical applications, aiming to enhance understanding and treatment of diseases through innovative approaches. - Emerging Technologies:
The integration of novel technologies, including CRISPR, nanomedicine, and advanced imaging techniques, is a recurring theme, reflecting the journal's commitment to cutting-edge scientific advancements.
Trending and Emerging
- Role of Microbiome in Health and Disease:
Research on the human microbiome and its influence on health and disease is gaining momentum, particularly in relation to metabolic disorders, autoimmune diseases, and cancer. - Ferroptosis and Regulated Cell Death:
The exploration of ferroptosis and other forms of regulated cell death is becoming increasingly prominent, particularly in the context of cancer and neurodegenerative diseases, as researchers seek to understand and manipulate these pathways for therapeutic benefit. - Advanced Biomaterials and Regenerative Medicine:
There is a growing interest in the development of innovative biomaterials and their applications in regenerative medicine, including tissue engineering and wound healing. - Gene Editing and CRISPR Technologies:
The application of CRISPR and other gene-editing technologies is emerging as a significant area of research, with studies exploring their potential in treating genetic disorders and cancer. - Immunotherapy Innovations:
Immunological approaches, particularly novel immunotherapies for cancer and autoimmune disorders, are trending, with increased focus on understanding immune checkpoints and developing combination therapies. - Personalized Medicine and Genomic Approaches:
The journal is increasingly publishing research that focuses on personalized medicine, utilizing genomic data to tailor treatments to individual patients based on their unique genetic and molecular profiles.
Declining or Waning
- Traditional Pharmacology and Single-Agent Studies:
There has been a noticeable decline in studies focused solely on traditional pharmacological approaches and single-agent therapies, as the field increasingly moves towards combination therapies and personalized medicine. - Basic Mechanistic Studies Without Clinical Relevance:
Papers that focus exclusively on basic mechanistic insights without clear clinical implications or translational potential are appearing less frequently as the journal prioritizes research that bridges basic science with clinical applications. - Animal Models of Disease:
Research relying heavily on conventional animal models without addressing translational relevance is declining, as there is a growing emphasis on humanized models or more sophisticated in vitro systems that better mimic human pathophysiology. - Static Disease Models:
Studies employing static models of disease that do not incorporate dynamic or multi-faceted approaches are less common, as researchers favor more comprehensive systems that reflect the complexities of human diseases.
Similar Journals
MedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.
CELLULAR AND MOLECULAR LIFE SCIENCES
Pioneering Innovative Insights in Molecular BiologyCELLULAR AND MOLECULAR LIFE SCIENCES, published by SPRINGER BASEL AG, stands as a premier journal dedicated to advancing the field of cellular and molecular biology. With an impressive 2023 impact factor reflected in its Q1 rankings across key categories—including Cell Biology, Molecular Biology, and Pharmacology—it serves as a critical platform for researchers aiming to disseminate high-quality findings in these dynamic fields. Operated under an open access framework, the journal allows broader accessibility to groundbreaking research, fostering collaboration amongst scientists globally. Based in Switzerland, CELLULAR AND MOLECULAR LIFE SCIENCES has been at the forefront of scientific publishing since 1952, adapting to contemporary scientific challenges and trends, ultimately shaping the future of life sciences.
CURRENT MOLECULAR MEDICINE
Empowering Research for Tomorrow’s Medical BreakthroughsCURRENT MOLECULAR MEDICINE is a pivotal journal fostering advancements in the interdisciplinary fields of molecular medicine, biochemistry, and genetics. Published by Bentham Science Publishers, this esteemed journal has been disseminating vital research findings since its inception in 2001 and is continuously dedicated to exploring the molecular basis of health and disease. With a focus on translational research, CURRENT MOLECULAR MEDICINE provides an invaluable platform for researchers, healthcare professionals, and students, making significant contributions to the understanding of molecular mechanisms and therapeutic strategies. With an ISSN of 1566-5240 and an E-ISSN of 1875-5666, the journal holds a commendable position within the scientific community, being ranked Q3 in Biochemistry and Molecular Biology and Q2 in Medicine (miscellaneous) as of 2023. This journal does not currently operate on an open access model but remains accessible through various institutional subscriptions. The multidisciplinary scope covering molecular biology to medicinal applications positions CURRENT MOLECULAR MEDICINE as an essential resource for those striving to meet the challenges of modern healthcare and biomedical research.
Molecular Medicine Reports
Connecting Researchers for a Healthier TomorrowMolecular Medicine Reports, an esteemed academic journal published by Spandidos Publications Ltd, serves as a vital platform for the dissemination of cutting-edge research in the field of molecular medicine. Established in 2008, this journal has rapidly ascended in prominence, currently positioned within the Q2 and Q3 quartiles across various critical categories including Biochemistry, Cancer Research, and Genetics, reflecting its significant impact and scholarly contributions. With an impressive Scopus ranking in multiple disciplines, including an 87th place in Oncology, it is recognized for publishing rigorous, peer-reviewed articles that bridge the gap between laboratory research and clinical applications. The journal’s commitment to advancing knowledge in molecular medicine is evident through its focus on innovative therapeutic approaches, genetic research, and oncological studies, catering to a diverse readership of researchers, professionals, and students in the biomedical field. Though not an open-access publication, it provides invaluable insights and fosters collaboration in the scientific community from its base in Athens, Greece.
CELLULAR & MOLECULAR BIOLOGY LETTERS
Bridging Gaps in Cellular Research for a Global AudienceCELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.
MOLECULAR MEDICINE
Elevating the Standards of Peer-Reviewed ScienceMOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.
RNA Biology
Unraveling the Complexities of RNA ScienceRNA Biology is a premier journal published by Taylor & Francis Inc, focusing on the intricate and evolving field of RNA research. With an ISSN of 1547-6286 and E-ISSN of 1555-8584, this journal has established itself as an essential resource for professionals, researchers, and students engaged in both molecular and cell biology. Recognized in the 2023 quartile rankings, RNA Biology holds a distinguished Q1 category in Molecular Biology and a Q2 category in Cell Biology, indicative of its significant impact and reputation within the scientific community. The journal emphasizes the importance of RNA in various biological processes, highlighting both fundamental and applied aspects, which is crucial for advancing our understanding of gene expression and regulation. With a strong Scopus ranking, including Rank #105/410 in Molecular Biology and Rank #83/285 in Cell Biology, RNA Biology is not just a publication but a vital platform for sharing groundbreaking findings and insights into RNA research. With a convergence that spans from 2004 to 2024, the journal promises to continue its legacy of excellence in disseminating important discoveries in RNA science, contributing richly to ongoing scientific dialogue and innovation.
International Journal of Biological Sciences
Connecting Researchers to the Pulse of Life SciencesInternational Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.
Non-Coding RNA
Leading the Charge in Non-Coding RNA InsightsNon-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
Catalyzing Advances in Nucleic Acid ScienceNUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS is a vital academic journal published by Taylor & Francis Inc, dedicated to the intricate and evolving domains of biochemistry, genetics, and molecular medicine. With an ISSN of 1525-7770 and E-ISSN of 1532-2335, this journal aims to provide a comprehensive platform for the dissemination of research findings, reviews, and methodologies related to nucleosides, nucleotides, and nucleic acids. As a research journal thriving since its inception in 2000, it reflects a diverse spectrum of studies crucial for advancing knowledge in biochemistry (ranked Q4) and genetics (Q4), while also achieving Q3 status in medicine (miscellaneous). Despite its current standing in the quartiles and Scopus rankings indicative of an emergent trajectory, the journal retains significant relevance for those delving into interdisciplinary research that intersects these fields. Researchers, professionals, and students alike can explore a plethora of original research articles, thought-provoking reviews, and updates on pioneering advances that shape our understanding of molecular biology. With its unwavering commitment to scholarly excellence, NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS continues to be an essential resource for those aiming to contribute to and stay informed about this pivotal area of scientific inquiry.